Akèy › Metiyè › Biochemists and Biophysicists › Seattle, WA
Biochemists and Biophysicists nan Seattle, WA: Salè H-1B
209 aplikasyon kondisyon travay pou okipasyon sa a ak yon sit travay nan Seattle, WA. Salè baz medyàn ofri $80,112; mwatye mitan $70,839–$94,650.
Demann (LCA)209
Salè medyan ofri$80,112
Mwatye salè yo$70,839–$94,650
10yèm–90yèm pousantaj$65,484–$120,439
Pa nivo salè
| Nivo revni | Salè medyan |
|---|---|
| Nivo I (antre) | $75,312 |
| Nivo II (kalifye) | $82,200 |
| Nivo III (eksperyans) | $92,982 |
| Nivo IV (plen kompetans) | $135,200 |
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Anplwayè yo
| Anplwayè | LCA | Salè medyan |
|---|---|---|
| University of Washington | 58 | $73,440 |
| Allen Institute | 58 | $90,000 |
| Fred Hutchinson Cancer Center | 43 | $77,976 |
| Howard Hughes Medical Institute | 11 | $77,969 |
| Seattle Children's Hospital | 8 | $66,095 |
| Shape Therapeutics Inc. | 7 | $96,000 |
| Institute for Systems Biology | 5 | $63,107 |
| Just-Evotec Biologics, Inc. | 4 | $125,100 |
| Lumen Bioscience, Inc. | 4 | $96,704 |
| Bristol-Myers Squibb Company | 2 | $211,120 |
| Juno Therapeutics, Inc. | 1 | $159,650 |
| NanoString Technologies, Inc. | 1 | $108,410 |
| Sage Bionetworks | 1 | $120,000 |
| Curi Bio Inc. | 1 | $125,000 |
| Amazon.com Services LLC | 1 | $160,000 |
| Callio Operating Co., Inc. | 1 | $290,000 |
| Xaira Therapeutics, Inc. | 1 | $192,000 |
| ImmunityBio, Inc. | 1 | $97,714 |
| Bruker Spatial Biology | 1 | $98,000 |
Tit travay
- Scientist I27
- Postdoctoral Scholar25
- Acting Instructor20
- Postdoctoral Research Fellow20
- Scientist II20
- Staff Scientist9
- Research Associate6
- Research Scientist/Engineer 36
- Research Scientist5
- Post-Doctoral Research Fellow5
- Research Specialist4
- Scientist III4
- Acting Assistant Professor4
- Senior Scientist4
- Associate Scientist4
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).